Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer

The irregular response to PARPi in HRD-positive and -negative tumors highlights the need for identifying additional biomarkers. This study explores the mutational landscape beyond HRD status in AOC, ultimately advancing precision oncology in future clinical practice.

Authors

Institutions

Publication Details

Journal
Cancer Research Communications
Published
2024-11-26
DOI
https://doi.org/10.1158/2767-9764.crc-24-0294
Citations
4
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
1.13

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer

Martin Schønemann‐Lund, Hanna Dahlstrand, Line Bjørge, Anne Krejbjerg et al.
4 citations
Cancer Research Communications
PARP inhibition in cancer therapy
1.13
article

Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer

Martin Schønemann‐Lund, Hanna Dahlstrand, Line Bjørge, Anne Krejbjerg, Charlotte Aaquist Haslund, Maria Rossing, Theresa L. Werner, Gitte-Bettina Nyvang, Maj K. Kjeldsen, Lars Fokdal, Maarit Anttila, Dina Sofie B. Grønseth, Susanne Malander, Trine Zeeberg Iversen, Gabriel Lindahl, Anja Ør Knudsen, Mansoor Raza Mirza, Sakari Hietanen, Michael J. Birrer, Maria Dimoula, Johanna Mäenpää, Morten Hulvej Jørgensen
article en
4 citations

Abstract

The irregular response to PARPi in HRD-positive and -negative tumors highlights the need for identifying additional biomarkers. This study explores the mutational landscape beyond HRD status in AOC, ultimately advancing precision oncology in future clinical practice.

Cancer Research CommunicationsVol. 4(12)
Linköping University (SE), University of Copenhagen (DK), Karolinska University Hospital (SE), Uppsala University Hospital (SE), University of Southern Denmark (DK), Aalborg University Hospital (DK), Haukeland University Hospital (NO), Huntsman Cancer Institute (US), Odense University Hospital (DK), Herlev Hospital (DK), Turku University Hospital (FI), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), Nordic Society of Gynecologic Oncology (DK), Kuopio University Hospital (FI), Region of Southern Denmark (DK), Tampere University Hospital (FI), Winthrop Rockefeller Foundation (US), Tampere University (FI), Skåne University Hospital (SE), University of Bergen (NO)
Rigshospitalet
Good health and well-being
Openalex Percentile: Top 18%
PARP inhibition in cancer therapy
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.